(Q65383477)

English

Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Study Assessing Safety, Tolerability, Immunogenicity of Three Dose Levels of ACAM3000 Modified Vaccinia Ankara Smallpox Vaccine in Adults With and Without Previous Smallpox Vaccination (English)

0 references

medical condition

smallpox

0 references

start time

July 2005

0 references

end time

June 2006

0 references

number of participants

590